AU2730801A - Survivin promotion of angiogenesis - Google Patents

Survivin promotion of angiogenesis

Info

Publication number: AU2730801A
Authority: AU; Australia
Prior art keywords: survivin; angiogenesis; promotion; survivin promotion
Prior art date: 1999-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU27308/01A

Inventor

Dario C. Altieria

William C. Sessa

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Yale University

Original Assignee

Yale University

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-12-21

Filing date

2000-12-21

Publication date

2001-07-03

2000-12-21 Application filed by Yale University filed Critical Yale University

2001-07-03 Publication of AU2730801A publication Critical patent/AU2730801A/en

Status Abandoned legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Zoology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Urology & Nephrology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Materials For Medical Uses (AREA)

AU27308/01A 1999-12-21 2000-12-21 Survivin promotion of angiogenesis Abandoned AU2730801A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US17299199P	1999-12-21	1999-12-21
US60172991		1999-12-21
PCT/US2000/034663 WO2001046455A2 (en)	1999-12-21	2000-12-21	Survivin promotion of angiogenesis

Publications (1)

Publication Number	Publication Date
AU2730801A true AU2730801A (en)	2001-07-03

Family

ID=22630045

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU27308/01A Abandoned AU2730801A (en)	1999-12-21	2000-12-21	Survivin promotion of angiogenesis

Country Status (6)

Country	Link
EP (1)	EP1242050A4 (en)
JP (1)	JP2003529554A (en)
AU (1)	AU2730801A (en)
CA (1)	CA2393646A1 (en)
MX (1)	MXPA02006167A (en)
WO (1)	WO2001046455A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6900187B2 (en)	1999-02-26	2005-05-31	The University Of British Columbia	TRPM-2 antisense therapy using an oligonucleotide having 2′-O-(2-methoxy)ethyl modifications
IL144975A0 (en)	1999-02-26	2002-06-30	Univ British Columbia	A composition containing an antisense oligonucleotide
US7569551B2 (en)	2000-02-25	2009-08-04	The University Of British Columbia	Chemo- and radiation-sensitization of cancer by antisense TRPM-2 oligodeoxynucleotides
WO2002007732A2 (en) *	2000-07-26	2002-01-31	Cambridge University Technical Services Limited	Use of panaxatriol for stimulation angiogenesis
CA2469685C (en)	2002-01-17	2013-03-12	The University Of British Columbia	Bispecific antisense oligonucleotides that inhibit igfbp-2 and igfbp-5 and methods of using same
CA2494764C (en)	2002-08-21	2013-04-23	The University Of British Columbia	Treatment of melanoma by reduction in clusterin levels
US7713738B2 (en)	2003-02-10	2010-05-11	Enzon Pharmaceuticals, Inc.	Oligomeric compounds for the modulation of survivin expression
CA2522730A1 (en) *	2003-04-18	2004-11-04	The Trustees Of The University Of Pennsylvania	Compositions and methods for sirna inhibition of angiopoietin 1 and 2 and their receptor tie2
US8710020B2 (en)	2004-04-02	2014-04-29	The University Of British Columbia	Clusterin antisense therapy for treatment of cancer
US20060154888A1 (en)	2004-11-09	2006-07-13	Santaris Pharma A/S	LNA oligonucleotides and the treatment of cancer
WO2009043104A1 (en) *	2007-10-04	2009-04-09	Bionomics Limited	Markers of endothelial cells and uses thereof
FR2932086A1 (en) *	2008-06-06	2009-12-11	Lvmh Rech	ANTI-AGE COSMETIC CARE METHOD BY STIMULATING THE EXPRESSION OF SURVIVAL
WO2014146030A1 (en)	2013-03-15	2014-09-18	Iris International, Inc.	Flowcell systems and methods for particle analysis in blood samples
KR102773176B1 (en)	2015-09-04	2025-02-27	헬스 리서치 인코포레이티드	Anti-Servivin Antibodies for Cancer Therapy

2000
- 2000-12-21 AU AU27308/01A patent/AU2730801A/en not_active Abandoned
- 2000-12-21 WO PCT/US2000/034663 patent/WO2001046455A2/en not_active Ceased
- 2000-12-21 MX MXPA02006167A patent/MXPA02006167A/en unknown
- 2000-12-21 CA CA002393646A patent/CA2393646A1/en not_active Abandoned
- 2000-12-21 JP JP2001546951A patent/JP2003529554A/en active Pending
- 2000-12-21 EP EP00990262A patent/EP1242050A4/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1242050A4 (en)	2004-05-26
CA2393646A1 (en)	2001-06-28
MXPA02006167A (en)	2004-02-26
WO2001046455A3 (en)	2002-05-10
WO2001046455A2 (en)	2001-06-28
EP1242050A2 (en)	2002-09-25
JP2003529554A (en)	2003-10-07

Publication	Publication Date	Title
AU1278701A (en)	2001-05-14	Novel compounds
AU6281100A (en)	2001-03-05	Novel diketopiperazines
AU7561300A (en)	2001-04-24	Novel flavonoids
AU2730801A (en)	2001-07-03	Survivin promotion of angiogenesis
AU3771000A (en)	2000-10-09	Method of promoting angiogenesis
AU2567300A (en)	2000-08-29	Inhibition of angiogenesis with epigallocatechin-3-gallate
AU5429000A (en)	2001-01-31	Novel bicyclonucleoside derivatives
AUPQ441499A0 (en)	2000-01-06	Novel compound
AU3670000A (en)	2000-10-23	Novel thiazolobenzimidazole derivatives
AU5166700A (en)	2000-12-18	C-cam as an angiogenesis inhibitor
AU5252900A (en)	2000-12-28	Novel isocoumarin derivatives inhibiting angiogenesis
AU2359301A (en)	2001-06-04	Novel ss-defensins
AU4132200A (en)	2000-11-10	Novel compounds
AU2109700A (en)	2000-08-07	Novel compounds
AU5646300A (en)	2000-08-29	Methods of stimulating angiogenesis
AU7711800A (en)	2001-04-24	Novel uses of 2-bromopalmitate
AU7348998A (en)	1998-12-08	Inhibition of angiogenesis by verotoxins
AU7448300A (en)	2001-05-10	Novel pyridine derivatives
AU2300000A (en)	2001-02-19	Novel uses of abca-type transporters
AU4156800A (en)	2000-10-09	Novel compounds
AU2288900A (en)	2000-08-01	Novel compounds
AU2939100A (en)	2000-09-28	Promoters
AU2985200A (en)	2000-08-25	Novel sialoadhesins
AU7784700A (en)	2001-04-30	Novel compounds
AU1385701A (en)	2001-05-08	Novel compounds

Legal Events

Date	Code	Title	Description
2002-08-29	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase